Here we provide a detailed procedure for production, purification, and quantification of high-titer recombinant Newcastle disease virus. This protocol consistently yields > 6 × 109 plaque-forming units/mL, providing virus quantities appropriate for in vivo animal studies. Additional quality control assays to ensure safety in vivo are described.
Yates, J. G. E., Leacy, A., Pham, P. H., Zielinska, N., Tusnadi, E. A., Susta, L., Wootton, S. K. Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid. J. Vis. Exp. (183), e63817, doi:10.3791/63817 (2022).